HI
RMD icon

Humankind Investments’s ResMed RMD Stock Holding History

Humankind Investments’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-1,321
Closed -$362K – 130
2025
Q3 		$362K Sell
1,321
-114
-8% -$31.1K 0.08% 96
2025
Q2 		$370K Buy
1,435
+120
+9% +$28.6K 0.09% 94
2025
Q1 		$294K Buy
1,315
+40
+3% +$9.34K 0.08% 116
2024
Q4 		$292K Buy
1,275
+11
+0.9% +$2.65K 0.07% 119
2024
Q3 		$309K Buy
1,264
+27
+2% +$6.03K 0.11% 110
2024
Q2 		$237K Buy
1,237
+89
+8% +$18.1K 0.06% 123
2024
Q1 		$227K Sell
1,148
-164
-13% -$30.1K 0.06% 125
2023
Q4 		$226K Buy
+1,312
New +$202K 0.07% 124

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Humankind Investments's RMD Position: Q4 2025 in Review

Humankind Investments sold out of ResMed (RMD) in Q4 2025, closing a stake of 1,321 shares — an estimated $362K sold.

Humankind Investments first reported a position in RMD in Q4 2023 and held it in 8 quarters. The position peaked at $370K in Q2 2025. 945 funds tracked by Wall St. Rank hold RMD as of Q4 2025.

  • Humankind Investments reported no remaining ResMed position as of Q4 2025 after selling out during the quarter.
  • Humankind Investments sold 1,321 ResMed shares in Q4 2025, an estimated $362K.
  • Humankind Investments first reported a position in ResMed in Q4 2023 and held it in 8 quarters.
  • Humankind Investments's ResMed position peaked at $370K in Q2 2025.
  • 945 funds tracked by Wall St. Rank held ResMed as of Q4 2025.

Based on Humankind Investments's 13F filing for Q4 2025, filed 17 Feb 2026.